about
Epidemiology of invasive candidiasis: a persistent public health problemResults from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testNewer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingNew and investigational triazole agents for the treatment of invasive fungal infections.In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.Design and synthesis of new fluconazole analogues.In vitro susceptibility of environmental isolates of Exophiala dermatitidis to five antifungal drugs.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolatesActivity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by useIn vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methodsIn vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis.
P2860
Q29616758-8DB4BE2E-B494-4D10-860F-0B535B078E98Q35913918-47BE30F3-9592-46A7-A731-B1679D16E483Q36491819-A6A3D9C3-E354-4A98-B140-4E595F389A77Q37051529-2655AE5F-4D6C-445A-9F5C-42E57FEC9EF1Q37364295-7FD89F76-947E-4963-A29D-C74F6607E38EQ38725931-BA3C3F16-B478-49E4-899C-27E9072329DAQ38874757-732FDEF2-DE90-4219-9BE6-8222BDE527EBQ39505421-DB62DF41-CF7A-44BC-89E7-553282464D34Q39899742-5A0EAD5C-35EA-4A64-8E76-0DFED307EFC4Q40189236-84C59CC1-95FB-4744-AD04-562A160EAE9EQ41859593-86AA17F4-CE52-4CBE-AC8C-85D27AFFA277Q41908299-5C540503-2287-4F97-A811-588B7E0B07C0Q41969487-98C1D44A-BE01-453F-B12E-3A5CF5932B34Q42076268-AACB268A-C569-42C5-9AEC-01CC55961210Q42727587-58F62A51-465D-4396-9E2F-2CD794DAF322
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Emerging azole antifungals.
@ast
Emerging azole antifungals.
@en
type
label
Emerging azole antifungals.
@ast
Emerging azole antifungals.
@en
prefLabel
Emerging azole antifungals.
@ast
Emerging azole antifungals.
@en
P2860
P356
P1476
Emerging azole antifungals.
@en
P2093
Jack D Sobel
P2860
P356
10.1517/14728214.10.1.21
P407
P577
2005-02-01T00:00:00Z